These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7601944)

  • 1. Scleromyxedema.
    Dinneen AM; Dicken CH
    J Am Acad Dermatol; 1995 Jul; 33(1):37-43. PubMed ID: 7601944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleromyxedema: a scleroderma-like disorder with systemic manifestations.
    Gabriel SE; Perry HO; Oleson GB; Bowles CA
    Medicine (Baltimore); 1988 Jan; 67(1):58-65. PubMed ID: 3336281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation.
    Lacy MQ; Hogan WJ; Gertz MA; Dispenzieri A; Rajkumar SV; Hayman S; Kumar S; Litzow MR; Schroeter AL
    Arch Dermatol; 2005 Oct; 141(10):1277-82. PubMed ID: 16230566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial scleromyxedema. Successful treatment with melphalan].
    Schubert K; Stein A; Meurer M
    Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arndt-Gottron scleromyxedema and associated phenomena].
    Lang E; Zabel M; Schmidt H
    Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleromyxedema: a complete response to prednisone.
    Rayson D; Lust JA; Duncan A; Su WP
    Mayo Clin Proc; 1999 May; 74(5):481-4. PubMed ID: 10319080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleromyxedema.
    Wright RC; Franco RS; Denton D; Blaney DJ
    Arch Dermatol; 1976 Jan; 112(1):63-6. PubMed ID: 813582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.
    Donato ML; Feasel AM; Weber DM; Prieto VG; Giralt SA; Champlin RE; Duvic M
    Blood; 2006 Jan; 107(2):463-6. PubMed ID: 16179379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleromyxedema. A dramatic response to melphalan.
    Feldman P; Shapiro L; Pick AI; Slatkin MH
    Arch Dermatol; 1969 Jan; 99(1):51-6. PubMed ID: 4178219
    [No Abstract]   [Full Text] [Related]  

  • 10. Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation.
    Chockalingam R; Duvic M
    Int J Dermatol; 2016 Oct; 55(10):e539-43. PubMed ID: 27207484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of scleromyxedema with melphalan.
    Harris RB; Perry HO; Kyle RA; Winkelmann RK
    Arch Dermatol; 1979 Mar; 115(3):295-9. PubMed ID: 434843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleromyxedema.
    Chanda JJ
    Cutis; 1979 Nov; 24(5):549-52. PubMed ID: 520033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin.
    Kulczycki A; Nelson M; Eisen A; Heffernan M
    Br J Dermatol; 2003 Dec; 149(6):1276-81. PubMed ID: 14674909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms.
    Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT
    Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus].
    D'Incan M; Franck F; Kanold J; Bacin F; Achin R; Beyvin AJ; Demeocq F; Souteyrand P
    Ann Dermatol Venereol; 2001 Jan; 128(1):38-41. PubMed ID: 11226899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
    Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal scleromyxedema: report of a case and review of the literature.
    Godby A; Bergstresser PR; Chaker B; Pandya AG
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):289-94. PubMed ID: 9486700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scleromyxedema: immunosuppressive therapy with cyclophosphamide].
    Aberer W; Wolff K
    Hautarzt; 1988 May; 39(5):277-80. PubMed ID: 3403262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two cases of scleromyxedema.
    Jepsen LV
    Acta Derm Venereol; 1980; 60(1):77-79. PubMed ID: 6153843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.